Viking Global Opportunities Illiquid Investments Sub-Master LP
Related Filers (30)
- VIKING GLOBAL INVESTORS LP (67)
- HALVORSEN OLE ANDREAS (67)
- Ott David C. (67)
- Viking Global Opportunities Portfolio GP LLC (67)
- Viking Global Opportunities GP LLC (67)
- Shabet Rose Sharon (60)
- Viking Global Opportunities Parent GP LLC (16)
- Urovant Sciences Ltd. (11)
- Sundheim Daniel S. (6)
- Axovant Gene Therapies Ltd. (5)
- Myovant Sciences Ltd. (4)
- BridgeBio Pharma, Inc. (4)
- Arbutus Biopharma Corp (4)
- Inhibrx, Inc. (4)
- Adaptive Biotechnologies Corp (4)
- 4D Molecular Therapeutics, Inc. (4)
- DRAGSA 50 LLC (4)
- Editas Medicine, Inc. (3)
- Zentalis Pharmaceuticals, Inc. (3)
- PROCEPT BioRobotics Corp (3)
- Amylyx Pharmaceuticals, Inc. (3)
- Rallybio Corp (3)
- Frazier Lifesciences Acquisition Corp (3)
- APi Group Corp (2)
- FIGS, Inc. (2)
- Ginkgo Bioworks Holdings, Inc. (2)
- DRAGSA 88 LLC (2)
- Roivant Sciences Ltd. (2)
- RayzeBio, Inc. (2)
- DRAGSA 96 LLC (1)
- Show More ...
Ownership (67)
4
Friday, 1/5/2024
4D Molecular Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
APi Group Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 9/21/2023
RayzeBio, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/14/2023
RayzeBio, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/19/2023
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/26/2023
Roivant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/11/2023
4D Molecular Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/25/2022
Frazier Lifesciences Acquisition Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Rallybio Corp: Statement of changes in beneficial ownership of securities
3
Friday, 11/4/2022
Frazier Lifesciences Acquisition Corp: Initial statement of beneficial ownership of securities
4
Friday, 11/4/2022
Frazier Lifesciences Acquisition Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/12/2022
Inhibrx, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/9/2022
Amylyx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/22/2022
PROCEPT BioRobotics Corp: Statement of changes in beneficial ownership of securities
4
Friday, 3/4/2022
Ginkgo Bioworks Holdings, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Amylyx Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/11/2022
Amylyx Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Friday, 10/1/2021
Roivant Sciences Ltd.: Initial statement of beneficial ownership of securities
3
Thursday, 9/23/2021
Ginkgo Bioworks Holdings, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/21/2021
PROCEPT BioRobotics Corp: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/14/2021
PROCEPT BioRobotics Corp: Initial statement of beneficial ownership of securities
4
Friday, 9/3/2021
FIGS, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/2/2021
Rallybio Corp: Statement of changes in beneficial ownership of securities
3
Thursday, 7/29/2021
Rallybio Corp: Initial statement of beneficial ownership of securities
3
Monday, 6/7/2021
FIGS, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/17/2020
4D Molecular Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/10/2020
4D Molecular Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/3/2020
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
Adaptive Biotechnologies Corp: Statement of changes in beneficial ownership of securities
4
Friday, 8/28/2020
Inhibrx, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 8/25/2020
Inhibrx, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 8/25/2020
Inhibrx, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/28/2020
APi Group Corp: Initial statement of beneficial ownership of securities
4
Wednesday, 4/8/2020
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 4/3/2020
Zentalis Pharmaceuticals, LLC: Initial statement of beneficial ownership of securities
4
Thursday, 1/30/2020
Adaptive Biotechnologies Corp: Statement of changes in beneficial ownership of securities
4
Friday, 7/12/2019
Myovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 7/12/2019
Arbutus Biopharma Corp: Statement of changes in beneficial ownership of securities
4
Friday, 7/12/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 7/12/2019
Axovant Gene Therapies Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/2/2019
Adaptive Biotechnologies Corp: Statement of changes in beneficial ownership of securities
4
Friday, 6/28/2019
BridgeBio Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/27/2019
BridgeBio Pharma, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 6/26/2019
Adaptive Biotechnologies Corp: Initial statement of beneficial ownership of securities
4
Wednesday, 6/19/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 6/14/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
Myovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/11/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/6/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 6/3/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/23/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 5/20/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/19/2019
Axovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/20/2018
Axovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/3/2018
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/26/2018
Urovant Sciences Ltd.: Initial statement of beneficial ownership of securities
4
Thursday, 6/7/2018
Axovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/5/2018
Myovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/16/2018
Arbutus Biopharma Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/17/2017
Arbutus Biopharma Corp: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/26/2016
Myovant Sciences Ltd.: Initial statement of beneficial ownership of securities
3
Wednesday, 7/13/2016
Arbutus Biopharma Corp: Initial statement of beneficial ownership of securities
3
Wednesday, 7/13/2016
Axovant Sciences Ltd.: Initial statement of beneficial ownership of securities
4/A
Tuesday, 2/9/2016
Editas Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/8/2016
Editas Medicine, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/2/2016
Editas Medicine, Inc.: Initial statement of beneficial ownership of securities